Initial Treatment Options for Metastatic TNBC : vimarsana.co

Dr Noor Abuhadra discusses the various first-line treatment options for metastatic TNBC, highlighting the importance of PDL1 expression for immunotherapy and germline testing for targeted therapies like PARP inhibitors. Patient Shay Elkins shares her treatment journey, from her initial chemo and immunotherapy to surgical intervention, emphasizing the importance of a collaborative approach with her healthcare team and the supportive role of nursing staff.

Related Keywords

, Metastatic Triple Negative Breast Cancer , Overcoming Challenges , Diagnosis Treatment , Treatment Options , Triple Negative Breast Cancer , Mtnbc , Overview , First Line Systemic Options , Testing , Treatment , Pdl1 Expression , Immunotherapy , Pembrolizumab , Germline Testing , Brca1 , Brca2 Mutations , Parp Inhibitors , Chemotherapy , Paclitaxelcarboplatin , Gemcitabine , Comorbidities , Patient Decision Making , Goals , Expectations , Side Effects , Support Groups , Nurse Role , Multidisciplinary Management , Patient Questions , Challenges , Unmet Needs , Supportive Nursing Staff , Treatment Support ,